Charles River Laboratories International (CRL) Competitors $172.22 -1.25 (-0.72%) As of 10:08 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CRL vs. ICLR, TECH, IQV, TMO, MTD, WAT, ILMN, BIO, BRKR, and PACBShould you be buying Charles River Laboratories International stock or one of its competitors? The main competitors of Charles River Laboratories International include Icon (ICLR), Bio-Techne (TECH), IQVIA (IQV), Thermo Fisher Scientific (TMO), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Rad Laboratories (BIO), Bruker (BRKR), and Pacific Biosciences of California (PACB). Charles River Laboratories International vs. Its Competitors Icon Bio-Techne IQVIA Thermo Fisher Scientific Mettler-Toledo International Waters Illumina Bio-Rad Laboratories Bruker Pacific Biosciences of California Icon (NASDAQ:ICLR) and Charles River Laboratories International (NYSE:CRL) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, media sentiment, profitability, analyst recommendations, institutional ownership and valuation. Which has more volatility & risk, ICLR or CRL? Icon has a beta of 1.23, suggesting that its stock price is 23% more volatile than the S&P 500. Comparatively, Charles River Laboratories International has a beta of 1.5, suggesting that its stock price is 50% more volatile than the S&P 500. Do institutionals & insiders hold more shares of ICLR or CRL? 95.6% of Icon shares are owned by institutional investors. Comparatively, 98.9% of Charles River Laboratories International shares are owned by institutional investors. 44.0% of Icon shares are owned by company insiders. Comparatively, 1.3% of Charles River Laboratories International shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Do analysts prefer ICLR or CRL? Icon presently has a consensus price target of $217.33, suggesting a potential upside of 16.20%. Charles River Laboratories International has a consensus price target of $179.93, suggesting a potential upside of 4.48%. Given Icon's stronger consensus rating and higher probable upside, equities analysts plainly believe Icon is more favorable than Charles River Laboratories International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Icon 0 Sell rating(s) 9 Hold rating(s) 9 Buy rating(s) 2 Strong Buy rating(s) 2.65Charles River Laboratories International 2 Sell rating(s) 7 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.35 Does the media refer more to ICLR or CRL? In the previous week, Icon had 6 more articles in the media than Charles River Laboratories International. MarketBeat recorded 17 mentions for Icon and 11 mentions for Charles River Laboratories International. Icon's average media sentiment score of 1.02 beat Charles River Laboratories International's score of 0.88 indicating that Icon is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Icon 7 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Charles River Laboratories International 4 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Which has stronger earnings and valuation, ICLR or CRL? Icon has higher revenue and earnings than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIcon$8.28B1.82$791.47M$9.7219.24Charles River Laboratories International$4.05B2.09$22.20M-$1.33-129.49 Is ICLR or CRL more profitable? Icon has a net margin of 9.82% compared to Charles River Laboratories International's net margin of -1.69%. Charles River Laboratories International's return on equity of 15.74% beat Icon's return on equity.Company Net Margins Return on Equity Return on Assets Icon9.82% 10.95% 6.23% Charles River Laboratories International -1.69%15.74%7.09% SummaryIcon beats Charles River Laboratories International on 12 of the 17 factors compared between the two stocks. Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRL vs. The Competition Export to ExcelMetricCharles River Laboratories InternationalMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$8.47B$8.20B$6.13B$22.00BDividend YieldN/A2.83%5.69%3.58%P/E Ratio-129.4475.1985.8629.79Price / Sales2.0933.00540.5365.14Price / Cash7.8422.8037.9224.43Price / Book2.547.0012.984.64Net Income$22.20M$247.60M$3.30B$1.01B7 Day Performance-1.82%1.25%4.73%0.38%1 Month Performance8.88%0.90%9.96%3.21%1 Year Performance-8.25%13.30%84.61%15.40% Charles River Laboratories International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRLCharles River Laboratories International4.2579 of 5 stars$172.22-0.7%$179.93+4.5%-7.1%$8.47B$4.05B-129.4420,100Analyst UpgradeICLRIcon4.0186 of 5 stars$163.44-0.2%$216.67+32.6%-35.2%$13.23B$8.28B16.8141,900Positive NewsAnalyst ForecastAnalyst RevisionTECHBio-Techne4.7811 of 5 stars$52.23+0.7%$70.42+34.8%-17.9%$8.07B$1.22B113.553,100Analyst UpgradeIQVIQVIA4.9058 of 5 stars$181.00+0.8%$229.64+26.9%-11.5%$30.53B$15.41B26.1988,000Positive NewsAnalyst ForecastTMOThermo Fisher Scientific4.8914 of 5 stars$461.95-0.5%$588.35+27.4%-9.9%$175.30B$42.88B26.72125,000Positive NewsAnalyst ForecastMTDMettler-Toledo International3.8999 of 5 stars$1,191.70-1.1%$1,325.56+11.2%-8.5%$24.81B$3.87B30.1817,300Analyst ForecastWATWaters4.5827 of 5 stars$289.19-0.9%$378.73+31.0%-8.6%$17.36B$2.96B26.087,600Trending NewsAnalyst ForecastILMNIllumina4.7718 of 5 stars$91.87+0.2%$123.06+33.9%-30.0%$14.09B$4.37B11.639,030Analyst ForecastBIOBio-Rad Laboratories4.3937 of 5 stars$269.95-0.5%$333.50+23.5%-10.8%$7.34B$2.57B23.017,700Positive NewsBRKRBruker4.9449 of 5 stars$30.88-0.5%$51.30+66.1%-46.7%$4.71B$3.37B59.3911,396Analyst ForecastPACBPacific Biosciences of California2.0183 of 5 stars$1.25+3.3%$1.90+52.0%-10.7%$363.45M$154.01M-0.55730News CoverageAnalyst Forecast Related Companies and Tools Related Companies Icon Alternatives Bio-Techne Alternatives IQVIA Alternatives Thermo Fisher Scientific Alternatives Mettler-Toledo International Alternatives Waters Alternatives Illumina Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CRL) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
